by GOAI

由GOAI生成

Share To

分享到

Jubilant Biosys has announced the opening of a new facility in India, which will significantly expand its capabilities in drug discovery research and scale-up projects. The company stated that the new site will double its chemistry capacity, enhancing its ability to support Contract Research, Development, and Manufacturing Organization (CRDMO) services..

Jubilant Biosys 宣布在印度开设了一家新设施，这将大幅扩展其在药物发现研究和规模化项目中的能力。该公司表示，新址将使其化学能力增加一倍，增强其对合同研究、开发和制造组织（CRDMO）服务的支持能力。

The expansion aims to address growing demands for advanced drug discovery solutions by increasing resources dedicated to chemistry-related research and development. This move is expected to bolster Jubilant Biosys’s role in supporting pharmaceutical companies with both early-stage research and larger-scale production needs.

此次扩建旨在通过增加用于化学相关研究和开发的资源，来满足对先进药物研发解决方案不断增长的需求。此举预计将加强 Jubilant Biosys 在支持制药公司进行早期研究及大规模生产需求方面的作用。

Further details about the facility’s location or operational timeline were not disclosed at this time..

目前尚未披露有关该设施位置或运营时间的更多细节。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

For any suggestion and feedback, please contact us.

如果有任何建议和反馈，请联系我们。

Date: January 12, 2026

日期：2026年1月12日

Related posts:

相关文章：

Drug Channels Institute Launches Six Interactive eLearning Modules on Pharmaceutical Economics

药物渠道研究所推出六个关于医药经济学的互动电子学习模块

Two-Stage Pimple Patch With Microscopic Spikes Clears Acne in Seven Days

两阶段微型尖刺痘痘贴七天内清除痤疮

Study Finds Elinzanetant Reduces Vasomotor Symptoms in Women Including Those on Endocrine Therapy

研究发现，Elinzanetant 可减少女性的血管舒缩症状，包括那些接受内分泌治疗的女性。

GLP-1 Drugs Aid Weight Loss but Require Support from Lifestyle and Public Health Strategies to Tackle Obesity

GLP-1药物有助于减肥，但需要生活方式和公共卫生战略的支持来应对肥胖问题。

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 保留所有权利。与我们合作：

[email protected]

电子邮件地址

Author

作者

GOAI

GOAI

Related Post

相关文章

News Flash

新闻快讯

Study Identifies SPAK as a Therapeutic Target to Inhibit Tumor Growth and Boost Immune Response in Liver Cancer

研究确定SPAK为抑制肝癌肿瘤生长和增强免疫反应的治疗靶点

2026-01-12

2026年1月12日